Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia have?
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia has 248 citations in the OpenAlex counts ScholarIQ stores.
When was Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia published?
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia has 2016 year in the ScholarIQ index.
What is the open-access status of Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia?
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia has hybrid oa status in the ScholarIQ index.
What is the DOI of Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia?
The DOI for Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia is on the source record.
What is the PMID of Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia?
The PMID for Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia is on the source record.
What is the OpenAlex record for Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia?
The OpenAlex for Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia is on the source record.